EMG Biosensors Sector: Growth Drivers and Challenges
Growth Drivers
- Growing Geriatric Population Across the Globe - Elderly people are more prone to neuromuscular diseases such as sarcopenia, and the rising number of elderly populations around the globe is estimated to drive market growth. Besides this, elderly people often need physical therapy in which EMG biosensors help in providing real-time feedback and monitoring the progress. According to estimates, the number of individuals in the world who are 60 or older will rise to over 2 billion by 2050.
- Surging Popularity of Minimally Invasive Surgery - The EMG treatment is non-invasive, and its non-invasive nature and practicality are thought to be the key drivers of its widespread implementation. EMG data are collected primarily via the non-invasive technique of skin surface sampling.
- Rising Demand for Wearable Devices - Wearable technology offers an alternative to clinical diagnostics with minimal invasiveness and can be used to track mental health, offer early diagnosis, and perform guided training.
- Increasing Prevalence of Neurological Diseases - Medical professionals frequently employ EMG instruments for the early diagnosis of neurological disorders and are being investigated more and more as assessment tools for impairment in neurological diseases. Moreover, Parkinson's disease one of the most significant in terms of the future global burden of diseases can be identified by EMG, and can also be used to track the effectiveness of treatment. For instance, neurological illnesses make up over 7% of the global incidence of illness.
Challenges
- Exorbitant Cost of EMG Biosensors - EMG biosensors include sensitive electrodes, amplifiers, and other advanced technology that necessitate substantial research and development, which raises the overall production costs. Besides this, the cost and difficulty of acquiring invasive electromyography and surface electromyography (sEMG) are high since they consume a lot of power.
- Inaccurate Data Can Lead to Incorrect Diagnosis and Misinterpretation
- Lack of Standardization and Regulation May Restrict Entry for New EMG Biosensor Technologies
- Privacy and Data Security Concerns
EMG Biosensors Market: Key Insights
|
Base Year |
2024 |
|
Forecast Year |
2025-2037 |
|
CAGR |
9.3% |
|
Base Year Market Size (2024) |
USD 683.13 million |
|
Forecast Year Market Size (2037) |
USD 2.17 billion |
|
Regional Scope |
|
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2025, the industry size of EMG biosensors is assessed at USD 737.13 million.
The EMG biosensors market size was valued at USD 683.13 million in 2024 and is expected to reach USD 2.17 billion by 2037, expanding at around 9.3% CAGR during the forecast period i.e., between 2025-2037. Rising cases of musculoskeletal disorders and growing technological advancements in EMG biosensors will drive the market growth.
North America industry is expected to hold largest revenue share of 40% by 2037, impelled by rising spending in healthcare in the region.
The major players in the market are OpenBCI Inc., Multi Biosensors Inc., Innopsys Inc., Biometrics Ltd., Butler Technologies, Inc., mDurance Solutions SL., iMotions A/S, Delsys Incorporated, Pinnacle Technology, and others.
